https://www.selleckchem.com/products/otssp167.html
There was no significant difference in recurrence-free survival (RFS) between the RR and LE groups among patients with tumors ≤2cm(P=0.22, and the RR group had a superior RFS than the LE group in patients with tumors 2cm(P=0.046). LE resulted in improved postoperative outcomes and comparable oncological safety with a low rectal GIST of ≤2cm. However, for patients with a low rectal GIST of 2cm, RR might be a more appropriate option with better RFS. 2 cm, RR might be a more appropriate option with better RFS. The Dutch Gynecolo